Adipocytic Progenitor Cells Give Rise to Pathogenic Myofibroblasts: Adipocyte-to-Mesenchymal Transition and Its Emerging Role in Fibrosis in Multiple Organs

    September 2020 in “ Current Rheumatology Reports
    Roberta Gonçalves Marangoni, Benjamin D. Korman, John Varga
    Studysummary This review discusses the emerging role of AMT in fibrosis and suggests that targeting AMT could offer a novel approach to treatment; it reports no new clinical results.
    Our plain-language summary. Not medical advice or a treatment recommendation. Consult a qualified healthcare professional before changing treatment. Full disclaimer
    The document discussed the process of adipocyte-to-mesenchymal transition (AMT), which occurred in multiple organs and diseases and involved transdifferentiation through a precursor cell. This process was reversible and could be influenced by factors such as metabolic stress, myeloid cells, immune dysregulation, and pharmacological intervention. AMT was recognized as a significant process in various forms of fibrosis, and targeting it could have served as a novel approach for treating fibrosis.
    Discuss this study in the Community →

    Research cited in this study

    11 / 11 results